title: Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes--in vitro study.
abstract: The present study was designed to examine therapeutic efficacy of the root extract of Stephania Tetrandra S. Moore (STMS) (traditional Chinese medicine; Han Fang Ji) for treatment of neovascularization of the retinal capillary (retinopathy) in streptozotocin (STZ)-induced diabetic rats (STZ diabetic rats) in culture. Recently we have established the culture system in which fetal bovine serum (FBS) in Dulbecco modified Eagle medium (DMEM) induced neovascularization of the retinal capillary and choroidal capillary in normal rats in culture. STZ diabetic rats showed more neovascularization of the retinal capillary and choroidal capillary than did normal rats in culture. In this study, the retinal tissue was removed for the posterior ocular region and cultured in DMEM containing FBS. The choroidal tissue of the posterior ocular region was also removed and cultured as an internal reference. Administration of STSM (0.91, 9.1 and 91 microg/ml) significantly suppressed neovascularization of the retinal capillary in both STZ diabetic rats and normal rats in a dose-dependent manner. Similar results were obtained with the choroidal capillary; administration of STSM suppressed neovascularization of the choroidal capillary in both STZ diabetic rats and normal rats. In order to determine the component of STSM inhibiting neovascularization of the retinal capillary, tetrandrine (a major chemical constituent of STSM) was administered and neovascularization of the retinal capillary was examined in culture. The effect of tetrandrine on the choroidal capillary was also examined as an internal reference. Administration of tetrandrine (0.1, 1.0 and 10 microM) suppressed neovascularization of the retinal capillary in both STZ diabetic rats and normal rats in a dose-dependent manner. Similar results were obtained with the choroidal capillary of both STZ diabetic rats and normal rats. We infer, therefore, that STSM has a direct effect on the retinal capillary of posterior ocular region and suppresses neovascularization of retinal capillary in STZ diabetic rats through the activation of tetrandrine. These results suggest that STSM may prevent for delay the progression of retinopathy in diabetic patients.
authors.affiliation: The Peking Union Medical College Hospital, Beijing, People's Republic of China.
authors.forename: Xiao-chun
authors.initials: XC
authors.lastname: Liang
authors.forename: Nobuyoshi
authors.initials: N
authors.lastname: Hagino
authors.forename: Sai-shan
authors.initials: SS
authors.lastname: Guo
authors.forename: Taiki
authors.initials: T
authors.lastname: Tsutsumi
authors.forename: Shinjiro
authors.initials: S
authors.lastname: Kobayashi
mesh_terms: D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D044182:Benzylisoquinolines; D002196:Capillaries / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D066298:In Vitro Techniques; D008297:Male; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D008517:Phytotherapy; D051381:Rats; D017207:Rats, Sprague-Dawley; D031609:Stephania tetrandra / Q000737:chemistry*; D013311:Streptozocin
chemical_list: D000470:Alkaloids; D044182:Benzylisoquinolines; C009438:tetrandrine; D013311:Streptozocin